Membrane trafficking in innate immunity to bacterial pathogens
膜运输对细菌病原体的先天免疫
基本信息
- 批准号:10238030
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-14 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 4-KinaseAnti-Bacterial AgentsAnti-Inflammatory AgentsAntibacterial ResponseAntigen PresentationAntigensAttentionAutophagocytosisBacteriaBacterial InfectionsBindingCD4 Positive T LymphocytesCell membraneCell surfaceCellsChloride ChannelsComplexCytoplasmic ReceptorsDataDefectDendritic CellsDetectionDisease modelEndosomesEnvironmentEnzymesFRAP1 geneFamilyGenetic DiseasesHermanski-Pudlak SyndromeHomeostasisHumanImmuneImmune System DiseasesImmune responseImmunityImmunologic Deficiency SyndromesImmunologic ReceptorsImpairmentInflammasomeInflammatoryInflammatory ResponseInnate Immune ResponseInterleukin-1Ion ChannelLeadLinkLipidsLysosomesMembraneMembrane Transport ProteinsModelingMolecularNatural ImmunityNatureNucleoside TransporterNutrientOligopeptidesOrganellesOutcomeParticulatePathway interactionsPatternPhagocytesPhagosomesPhosphatidylinositolsPlayPositioning AttributeProcessProductionPropertyProtein SortingsReceptor SignalingRegulationRoleSentinelSignal TransductionSiteSorting - Cell MovementStimulusTIRAP geneTLR4 geneTestingToll-like receptorsVesicleadaptive immune responseadaptive immunitycytokinefightinginorganic phosphatemicrobialmouse modelnovelpathogenpathogenic bacteriaphosphatidylinositol 4-phosphateprotein transportrare genetic disorderrecruitresponsetrafficking
项目摘要
SUMMARY
Anti-bacterial inflammatory responses in phagocytes are initiated by recognition of common pathogen
associated molecular patterns (PAMPs) by innate immune receptors. PAMP binding to membrane-associated
toll-like receptors (TLRs) at distinct subcellular sites triggers site-specific responses, and bacteria that
compromise phagosomal membranes additionally trigger cytoplasmic receptors, some of which assemble into
multisubunit inflammasomes that process and release IL-1 family cytokines. Membrane dynamics within host
phagocytes dramatically influence TLR and inflammasome localization and signaling, but host regulation of
such dynamics has been relatively unexplored. Our studies in a genetic disease model identified the
endosomal adaptor complex AP-3 as a central hub for intracellular trafficking pathways that regulate both TLR
and inflammasome responses to phagocytosed bacteria in dendritic cells (DCs) - immune cells that link innate
responses to adaptive immunity. However, AP-3 impacts these responses indirectly, reflecting AP-3's central
role in endolysosomal protein sorting. We hypothesize that defining direct targets of AP-3 sorting will elucidate
new membrane pathways controlling innate signaling and downstream anti-bacterial immune responses.
AP-3 sorts cargoes on endosomes into vesicles bound for lysosomes, phagosomes or related organelles. We
hypothesize that innate signaling defects in AP-3-deficient DCs reflect depletion of AP-3 cargoes from these
organelles. Preliminary data suggest that one such cargo is PI4K2α, an enzyme that generates the lipid
phosphatidylinositol-4-phosphate to recruit TLRs via their proinflammatory adaptors to membranes. Aim 1 will
test whether phagosomal PI4K2α recruits TLRs to initiate pro-inflammatory signaling and antigen presentation.
Other putative AP-3 cargoes include lysosomal transporters that function in lysosome homeostasis. We
hypothesize that depletion of such cargoes triggers a lysosome-dependent signaling cascade that promotes
inflammasome silencing by autophagy. Aim 2 will test whether and how lysosomal disruption impacts
inflammasome activity, and Aim 3 will test whether depletion of specific candidate lysosomal membrane
channels similarly silence inflammasomes and impact lysosome signaling and adaptive immune responses.
Fulfillment of the following Specific Aims will elucidate novel pathways that are potentially targeted by genetic
disease and/or by pathogen interference to compromise host immunity to bacterial pathogens.
1. To test whether TLR signaling from phagosomes and downstream responses are regulated by the
AP-3-associated PtdIns-4-kinase PI4K2α.
2. To test whether impaired lysosomal function dampens inflammasome activity through nutrient-
dependent signaling.
3. To test whether lysosomal membrane transporter expression influences inflammasome activation.
概括
吞噬细胞中的抗菌炎症反应是通过识别常见病原体引发的
与先天免疫接收器相关的分子图案(PAMP)。 pamp结合与膜相关的
在不同的亚细胞部位的收费样受体(TLR)触发特异性反应和细菌
折衷的吞噬体膜还触发细胞质受体,其中一些受体组装成
处理和释放IL-1家族细胞因子的多亚基炎症体。主机内的膜动力学
吞噬细胞动态影响TLR和炎症体的定位和信号传导,但宿主调节
这样的动态相对出乎意料。我们在遗传疾病模型中的研究确定了
内体适配器复合物AP-3作为调节两个TLR的细胞内运输途径的中心枢纽
以及对树突状细胞中吞噬细菌(DCS)的炎症反应 - 将先天性联系起来的免疫细胞
对适应性免疫学的反应。但是,AP-3间接影响这些响应,反映了AP-3的中心
在内溶性蛋白质分类中的作用。我们假设定义AP-3排序的直接目标将阐明
控制先天信号和下游抗细菌免疫调查的新膜途径。
AP-3将货物上的货物分类为融合的溶酶体,吞噬体或相关细胞器的蔬菜。我们
假设AP-3缺陷DC中的先天信号缺陷反映了AP-3货物的消耗
细胞器。初步数据表明,这样的货物是PI4K2α,一种生成脂质的酶
磷脂酰肌醇-4-磷酸盐通过其促炎的膜到膜上募集TLR。目标1意志
测试吞噬体PI4K2α食谱是否会启动促炎信号传导和抗原表现。
其他推定的AP-3货物包括在溶酶体稳态中起作用的溶酶体转运蛋白。我们
假设此类货物的依赖会触发促溶酶体依赖性信号级联
自噬的炎症体沉默。 AIM 2将测试溶酶体干扰是否以及如何影响
炎性体活动和AIM 3将测试特定候选溶酶体膜的耗尽
通道类似地沉默炎症,并影响溶酶体信号传导和适应性免疫调查。
实现以下特定目标将阐明遗传可能针对的新型途径
疾病和/或通过病原体干扰可损害细菌病原体的宿主免疫学。
1。测试来自吞噬体和下游响应的TLR信号是否由
AP-3相关的PTDINS-4-激酶PI4K2α。
2。为了测试受损的溶酶体功能是否通过营养抑制了炎症体活性 -
依赖的信号传导。
3。测试溶酶体膜转运蛋白表达是否会影响炎症体激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adriana Rita Mantegazza其他文献
Adriana Rita Mantegazza的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adriana Rita Mantegazza', 18)}}的其他基金
Membrane trafficking in innate immunity to bacterial pathogens
膜运输对细菌病原体的先天免疫
- 批准号:
10387196 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
Membrane trafficking in innate immunity to bacterial pathogens
膜运输对细菌病原体的先天免疫
- 批准号:
10488183 - 财政年份:2018
- 资助金额:
$ 39万 - 项目类别:
相似国自然基金
三种凤尾蕨属植物中吡咯生物碱及其抗菌和抗HCV病毒功能研究
- 批准号:82360689
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
基于乏氧增强型超声抗菌剂的细菌生物膜感染协同治疗研究
- 批准号:22375101
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非典型I-型聚酮类抗菌剂NFAT-133的芳构化机理
- 批准号:32211530074
- 批准年份:2022
- 资助金额:10 万元
- 项目类别:
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
- 批准号:82202575
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Membrane trafficking in innate immunity to bacterial pathogens
膜运输对细菌病原体的先天免疫
- 批准号:
10488183 - 财政年份:2018
- 资助金额:
$ 39万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7793450 - 财政年份:2006
- 资助金额:
$ 39万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7417794 - 财政年份:2006
- 资助金额:
$ 39万 - 项目类别: